2022-10-16T15:19:42-05:00 2021-12-31 990 2021-01-01 236434390 THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY WIST 2154956922 3601 SPRUCE STREET PHILADELPHIA PA 191044265 JOSEPH G TRAINOR CHIEF FINANCIAL OFFICER 2154956922 2022-10-16 JOSEPH TRAINOR 999009999 3 AAL1 IAL1 2021 2022-09-23 18:48:47Z JOSEPH G TRAINOR 3601 SPRUCE STREET PHILADELPHIA PA 19104 149604000 0 X WWW.WISTAR.ORG X 1892 PA BIOMEDICAL RESEARCH WITH SPECIAL EXPERTISE IN CANCER RESEARCH AND VACCINE DEVELOPMENT (IMMUNOLOGY). 32 32 386 46 472000 0 51614000 95470000 3021000 4522000 7974000 11133000 4654000 4706000 67263000 115831000 0 0 0 0 31420000 30517000 0 0 1289000 37487000 38574000 68907000 69091000 -1644000 46740000 343834000 414460000 77282000 79958000 266552000 334502000 X THE MISSION OF THE WISTAR INSTITUTE IS TO MARSHAL THE TALENTS OF OUTSTANDING SCIENTISTS THROUGH A HIGHLY ENABLED CULTURE OF BIOMEDICAL COLLABORATION AND INNOVATION IN ORDER TO SOLVE SOME OF THE WORLD'S MOST CHALLENGING AND IMPORTANT PROBLEMS IN THE FIELD OF CANCER AND IMMUNOLOGY, AND PRODUCE GROUND-BREAKING ADVANCES IN WORLD HEALTH. CONSISTENT WITH A PIONEERING LEGACY OF LEADERSHIP IN NOT-FOR-PROFIT BIOMEDICAL RESEARCH AND A TRACK-RECORD OF LIFE-SAVING CONTRIBUTIONS IN IMMUNOLOGY AND CELL BIOLOGY, THE WISTAR INSTITUTE AIMS TO PURSUE NOVEL AND COURAGEOUS RESEARCH PATHS TO LIFE SCIENCE DISCOVERY, AND TO ACCELERATE/POTENTIATE THE IMPACT OF THOSE DISCOVERIES BY SHORTENING THE PATH FROM BENCH TO BEDSIDE. 0 0 54703000 0 4522000 THE WISTAR INSTITUTE TAKES A COLLABORATIVE, TEAM APPROACH TO PURSUING NEW BIOMEDICAL RESEARCH DISCOVERIES THAT CAN BE TRANSLATED INTO NEXT-GENERATION THERAPEUTICS AND DIAGNOSTICS THROUGH MEANINGFUL PARTNERSHIPS. THE INSTITUTE'S RESEARCH ENTERPRISE IS ORGANIZED INTO TWO MAIN CENTERS: THE WISTAR INSTITUTE CANCER CENTER, WHICH HAS HELD THE NATIONAL CANCER INSTITUTE (NCI)-DESIGNATION SINCE 1972, AND THE VACCINE & IMMUNOTHERAPY CENTER. WISTAR SCIENTISTS BENEFIT FROM THE TECHNOLOGICAL SUPPORT AND STATE-OF-THE-ART INSTRUMENTATION PROVIDED BY THE INSTITUTE'S SHARED RESOURCES. WISTAR RESEARCHERS AND COLLABORATORS CONTINUE TO MAKE SIGNIFICANT, CUTTING-EDGE INSIGHTS INTO THE UNDERLYING MECHANISMS OF DISEASE TO CREATE NEW TARGETED THERAPIES AND IMMUNOTHERAPIES FOR CANCER. WISTAR HAS A PROVEN RECORD OF SUCCESS IN VACCINE DEVELOPMENT THAT HAS LED TO VACCINES AGAINST RUBELLA, RABIES, AND ROTAVIRUS. IN RESPONSE TO THE COVID-19 PANDEMIC, WISTAR SCIENTISTS ARE RESEARCHING INNOVATIVE PREVENTATIVE AND THERAPEUTIC SOLUTIONS FOR SARS-COV-2, INCLUDING A VACCINE DEVELOPED WITH COLLABORATORS IN ACADEMIA AND BIOTECH THAT IS PHASE 2 CLINICAL TESTING. IN LINE WITH ITS HISTORIC COMMITMENT TO EDUCATION AND TRAINING OF THE NEXT GENERATION OF SCIENTISTS, WISTAR HAS LAUNCHED NEW COLLABORATIONS WITH LOCAL AND INTERNATIONAL INSTITUTIONS WITH THE GOAL OF EXPANDING LIFE SCIENCE EDUCATION AND BUSINESS DEVELOPMENT OPPORTUNITIES IN PENNSYLVANIA AND BEYOND. WISTAR HAS A ROBUST RANGE OF STEM-BASED PROGRAMMING FOCUSED ON INCREASING ACCESS FOR UNDER-REPRESENTED POPULATIONS THROUGHOUT THE AREA. WISTAR'S EDUCATIONAL OUTREACH INCLUDES APPRENTICESHIPS, PATHWAYS PROGRAMMING, AND COMMUNITY OUTREACH TO SUPPORT STEM-BASED AND BIOMEDICAL RESEARCH CAREER OPPORTUNITIES. 54703000 1 1 0 1 0 0 0 1 0 1 1 1 0 1 1 1 1 0 0 0 1 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 0 0 1 151 0 386 1 1 1 0 0 0 0 1 1 0 0 0 0 0 0 X 32 32 1 0 0 0 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AR AZ CA CO CT FL GA HI IL KS KY MA MD ME MI MN MO MS NC ND NH NJ NM NY OH OK OR PA RI SC TN UT VA WA WI WV X JOSEPH G TRAINOR CFO 2154956922 3601 SPRUCE STREET PHILADELPHIA PA 191044265 STEVEN V ABRAMNSON TRUSTEE 1.00 X 0 0 0 ELIZABETH MCKEE ANDERSON TRUSTEE 2.00 X 0 0 0 DOUGLAS S BRIGGS TRUSTEE 1.00 X 0 0 0 IRA BRIND TRUSTEE 1.00 X 0 0 0 RONALD CAPLAN TRUSTEE 2.00 X 0 0 0 SCOTT COOPER TRUSTEE 1.00 X 0 0 0 ARTHUR DANTCHIK TRUSTEE 1.00 X 0 0 0 SUSAN B DILLON PHD TRUSTEE 1.00 X 0 0 0 BRIAN H DOVEY TRUSTEE 2.00 X 0 0 0 DANIEL K FITZPATRICK TRUSTEE 1.00 X 0 0 0 JOHN FRY TRUSTEE 1.00 X 0 0 0 JOSEPH A GOLDBLUM TRUSTEE 2.00 X 0 0 0 RICHARD M HOROWITZ TRUSTEE - BOARD VICE CHAIR 4.00 X X 0 0 0 PERRY A LERNER TRUSTEE 1.00 X 0 0 0 JAMES W LOVETT TRUSTEE 2.00 X 0 0 0 SUSAN S MCDONALD PHD TRUSTEE 2.00 X 0 0 0 ABRAHAM L MORRIS TRUSTEE 1.00 X 0 0 0 ARTHUR M PAPPAS TRUSTEE 1.00 X 0 0 0 RICHARD G PHILLIPS JR TRUSTEE 1.00 X 0 0 0 WENDELL PRITCHETT PHD TRUSTEE 1.00 X 0 0 0 HELEN P PUDLIN ESQ TRUSTEE - BOARD CHAIR 4.00 X X 0 0 0 SAMUEL V RHOADS TRUSTEE 1.00 X 0 0 0 ROBERT H ROCK TRUSTEE 1.00 X 0 0 0 GERALD B RORER TRUSTEE 1.00 X 0 0 0 ADELE K SCHAEFFER TRUSTEE 1.00 X 0 0 0 MILTON S SCHNEIDER TRUSTEE 1.00 X 0 0 0 WILLIAM A SLAUGHTER TRUSTEE 1.00 X 0 0 0 DANIEL H WHEELER TRUSTEE 2.00 X 0 0 0 EDWARD ZIFF PHD TRUSTEE 1.00 X 0 0 0 DARIO ALTIERI MD PRESIDENT & CEO, DIRECTOR OF WISTAR CANCER CENTER 55.00 X 643096 0 41678 DAVID B WEINER EXECUTIVE VICE PRESIDENT 55.00 X 438499 0 54177 JENNIFER EVANS STACEY VICE PRESIDENT, GEN COUNSEL, SEC & GOV RELATIONS 55.00 X 304784 0 45132 HEATHER A STEINMAN VP FOR BUSINESS DEVELOP & E.D. TECH 55.00 X 293576 0 46923 JOSEPH TRAINOR CHIEF FINANCIAL OFFICER 55.00 X 265681 0 52381 ANITA PEPPER VICE PRESIDENT, INSTITUTIONAL ADVANCEMENT 55.00 X 264851 0 35748 JOANN MENDEL VICE PRESIDENT, HUMAN RESOURCES 55.00 X 204007 0 33638 LUIS MONTANER PROFESSOR VICE PRESIDENT, SCIENTIFIC OPERATIONS 55.00 X 349845 0 61220 MEENHARD HERLYN PROFESSOR 55.00 X 280533 0 58847 DAVID SPEICHER PROFESSOR 55.00 X 255294 0 55491 RUGANG ZHANG PROFESSOR 55.00 X 261685 0 44715 HILDEGUND ERTL PROFESSOR 55.00 X 251424 0 36855 3813275 0 566805 61 0 1 0 THE ARTHUR JACKSON COMPANY 7025 WEST CHESTER PIKE UPPER DARBY PA 19082 JANITORIAL SERVICES 891000 ALLIED UNIVERSAL SECURITY SERVICES PO BOX 828854 PHILADELPHIA PA 191828854 SECURITY SERVICES 608000 MARA RESTORATION INC 150 ROESCH AVE ORELAND PA 19075 RESTORATION SERVICES 422000 TRIUMVIRATE ENVIRONMENTAL INC DEPT 106069 PO BOX 150502 HARTFORD CT 06115 WASTE MANAGEMENT 297000 JJ WHITE INC 5500 BINGHAM STREET PHILADELPHIA PA 19120 RESTORATION SERVICES 289000 15 35000 44757000 50678000 1772000 95470000 RESEARCH CONTRACT REVENUE 541700 4522000 4522000 4522000 7187000 7187000 4023000 4023000 236000 205000 31000 31000 31000 37512000 33566000 3946000 3946000 3946000 0 35000 2000 -2000 -2000 SALES OF SPECIALIZED SERVICES 541700 472000 472000 182000 182000 654000 115831000 4522000 472000 15367000 2724000 1177000 1246000 301000 21070000 16036000 4631000 403000 1924000 1566000 349000 9000 3317000 2329000 860000 128000 1482000 1128000 326000 28000 756000 756000 135000 135000 88000 88000 600000 600000 3216000 1784000 1122000 310000 54000 4000 50000 221000 152000 64000 5000 969000 226000 724000 19000 4317000 3966000 321000 30000 72000 72000 3000 3000 1323000 1160000 154000 9000 6709000 5884000 780000 45000 278000 278000 LAB SUPPLIES AND EQUIPM 9494000 9008000 486000 SUBAWARDS 9217000 9203000 14000 STIPENDS 884000 884000 TUITION, HONRARIUM, AND 68000 49000 17000 2000 170000 75000 95000 69091000 54703000 13099000 1289000 1355000 6729000 15570000 27166000 5095000 31442000 10118000 11815000 238000 389000 1258000 2045000 187995000 93741000 96745000 94254000 164050000 189261000 28499000 28548000 20906000 22811000 343834000 414460000 11665000 13148000 5772000 12019000 52698000 52725000 7147000 2066000 77282000 79958000 X 211645000 235004000 54907000 99498000 266552000 334502000 343834000 414460000 X 46740000 15313000 5897000 X 0 1 X 1 1 1 X 59722000 51780000 48234000 51614000 95470000 306820000 59722000 51780000 48234000 51614000 95470000 306820000 306820000 20308000 22625000 9938000 9496000 11446000 73813000 104000 293000 851000 216000 182000 1646000 382279000 16857000 0.80260 0.75390 X SCHEDULE A, PART II, LINE 8 INCLUDE $4,023,000 ROYALTIES, $7,187,000 DIVIDENDS AND INTEREST, AND $236,000 RENT REVENUE. SCHEDULE A, PART II, LINE 10 INCLUDE $182,000 MISCELLANEOUS INCOME (POWER REDUCTION REFUND AND OTHER MISCELLANEOUS REBATES). RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 0 0 0 1 88000 0 0 88000 0 PART II-B, LINE 1: THE WISTAR INSTITUTE ENGAGED THE SERVICES OF TWO LOBBYING FIRMS WHOSE RESPONSIBILITIES ARE TO PROVIDE GOVERNMENT RELATIONS SERVICES TO THE WISTAR INSTITUTE AT THE FEDERAL, STATE AND LOCAL LEVELS. DUTIES INCLUDE MONITORING AND TRACKING LEGISLATION WHICH MAY BE OF INTEREST TO THE WISTAR INSTITUTE, ARRANGING MEETINGS WITH LEGISLATORS AND ARRANGING VISITS OF LEGISLATORS TO THE WISTAR INSTITUTE, AND ASSISTING IN FINDING FUNDING SOURCES FOR PROGRAMS. IN ADDITION, A NUMBER OF WISTAR STAFF PARTICIPATE IN ADVOCACY ON A REGULAR BASIS BY PARTICIPATING IN VISITS TO LEGISLATIVE OFFICES IN HARRISBURG, PA AND BY HOSTING VISITS OF STATE AND FEDERAL LEGISLATORS TO THE WISTAR INSTITUTE. WE ALSO OCCASIONALLY ASK OUR BOARD, EMPLOYEES OR FRIENDS/VOLUNTEERS TO WRITE LETTERS OR CALL THEIR REPRESENTATIVES REGARDING LEGISLATION THAT MAY IMPACT WISTAR. X X X 0 62934000 286000 9350000 1070000 71500000 54250000 41000 9591000 948000 62934000 45876000 28000 9161000 815000 54250000 50072000 51000 -3526000 721000 45876000 43529000 73000 7249000 779000 50072000 0.68000 0.19000 0.13000 0 0 685000 685000 98112000 41556000 56556000 87700000 51279000 36421000 1498000 906000 592000 94254000 ALTERNATIVE INVESTMENTS 28548000 F 28548000 BENEFICIAL INTEREST IN CHARITABLE REMAINDER TRUSTS 1151000 BENEFICIAL INTEREST IN PERPETUAL TRUSTS 21660000 22811000 INTEREST RATE SWAP 2066000 2066000 X 136176000 15313000 5297000 20610000 115566000 265000 265000 115831000 68226000 207000 207000 68019000 1072000 1072000 69091000 PART III, LINE 1A: COLLECTIONS CONSIST OF FAMILY MEMORABILIA AND OTHER ARTIFACTS WHICH ARE NOT USED IN THE INSTITUTE'S OPERATIONS. PART III, LINE 4: THE INSTITUTE'S COLLECTIONS CONSTITUTE A HISTORY OF MEDICAL SCIENCE IN PHILADELPHIA AND THE HISTORY OF VACCINE DEVELOPMENT. THE MUSEUM COLLECTIONS ARE TIED TO OUR DEEDS OF TRUST AND HAVE SIGNIFICANT HISTORICAL VALUE, AS WISTAR WAS ESTABLISHED AS THE FIRST INDEPENDENT NONPROFIT BIOMEDICAL RESEARCH INSTITUTE IN THE COUNTRY. PART V, LINE 4: MANAGEMENT DETERMINES THE PRUDENT USE OF THE ENDOWMENT FUNDS TO SUPPORT GENERAL PURPOSES AND RESEARCH AND TRAINING PROGRAMS AS SPECIFIED BY THE VARIOUS ENDOWMENT PROGRAMS. PART X, LINE 2: THE INSTITUTE IS A NOT-FOR-PROFIT INSTITUTE WHICH HAS BEEN DETERMINED BY THE INTERNAL REVENUE SERVICE TO BE EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC). THE INSTITUTE ACCOUNTS FOR UNCERTAINTIES IN INCOME TAXES IN ACCORDANCE WITH AUTHORITATIVE GUIDANCE, WHICH PRESCRIBES A RECOGNITION THRESHOLD OF MORE-LIKELY-THAN-NOT TO BE SUSTAINED UPON EXAMINATION BY THE APPROPRIATE TAXING AUTHORITY. MEASUREMENT OF THE TAX UNCERTAINTY OCCURS IF THE RECOGNITION THRESHOLD HAS BEEN MET. MANAGEMENT BELIEVES THAT THERE WERE NO TAX UNCERTAINTIES THAT MET THE RECOGNITION THRESHOLD FOR THE YEAR 2021. PART XI, LINE 2D - OTHER ADJUSTMENTS: GAIN ON SPLIT-INTEREST AGREEMENTS 1,903,000. CHANGE IN CASH SURRENDER VALUE OF LIFE INSURANCE POLICIES 9,000. PENSION - NET GAIN 1,775,000. INTEREST RATE SWAP - NET GAIN 2,210,000. INVESTMENT MANAGEMENT FEES -600,000. PART XI, LINE 4B - OTHER ADJUSTMENTS: FUNDRAISING EVENT EXPENSE -2,000. RENTAL EXPENSE -205,000. UNRELATED BUSINESS RECEIPTS 472,000. PART XII, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EVENT EXPENSES 2,000. RENTAL EXPENSES 205,000. PART XII, LINE 4B - OTHER ADJUSTMENTS: INVESTMENT MANAGEMENT AND CUSTODIAL FEES 600,000. UNRELATED BUSINESS REVENUES 472,000. CENTRAL AMERICA AND THE CARIBBEAN 0 0 INVESTMENTS 22520000 0 0 0 0 0 0 22520000 0 22520000 1 0 1 1 1 0 PART III ACCOUNTING METHOD: PART IV, LINE 3 ALTHOUGH WISTAR MAINTAINS INTERESTS IN THESE FOREIGN CORPORATIONS AND PARTNERSHIPS, ITS OWNERSHIP PERCENTAGE DID NOT MEET THE THRESHOLD FOR REPORTING ON IRS FORM 5471 AND 8865. WISTAR MADE TRANSFERS TO FOREIGN CORPORATIONS THAT EXCEEDED THE THRESHOLD TO FILE FORM 926. WOMEN & SCIENCE 35000 35000 2000 35000 35000 2000 2000 -2000 X X X 0 1 X X X X 0 0 0 0 0 0 0 1 0 DARIO ALTIERI MD PRESIDENT & CEO, DIRECTOR OF WISTAR 595665 0 0 0 47431 0 37700 0 3978 0 684774 0 0 0 DAVID B WEINER EXECUTIVE VICE PRESIDENT 363031 0 70500 0 4968 0 35420 0 18757 0 492676 0 0 0 LUIS MONTANER PROFESSOR VICE PRESIDENT, SCIENTIFIC 268944 0 65500 0 15401 0 36900 0 24320 0 411065 0 0 0 JENNIFER EVANS STACEY VICE PRESIDENT, GEN COUNSEL, SEC & G 254914 0 35000 0 14870 0 34100 0 11032 0 349916 0 0 0 HEATHER A STEINMAN VP FOR BUSINESS DEVELOP & E.D. TECH 230243 0 63000 0 333 0 33540 0 13383 0 340499 0 0 0 MEENHARD HERLYN PROFESSOR 262564 0 15500 0 2469 0 37390 0 21457 0 339380 0 0 0 JOSEPH TRAINOR CHIEF FINANCIAL OFFICER 241766 0 20500 0 3415 0 32424 0 19957 0 318062 0 0 0 DAVID SPEICHER PROFESSOR 249247 0 500 0 5547 0 34034 0 21457 0 310785 0 0 0 RUGANG ZHANG PROFESSOR 260870 0 500 0 315 0 33702 0 11013 0 306400 0 0 0 ANITA PEPPER VICE PRESIDENT, INSTITUTIONAL ADVANC 248980 0 15500 0 371 0 32150 0 3598 0 300599 0 0 0 HILDEGUND ERTL PROFESSOR 207846 0 40500 0 3078 0 32802 0 4053 0 288279 0 0 0 JOANN MENDEL VICE PRESIDENT, HUMAN RESOURCES 187463 0 15500 0 1044 0 24647 0 8991 0 237645 0 0 0 PART I, LINE 1A TAX INDEMNIFICATION AND GROSS-UP PAYMENTS INCLUDE TUITION BENEFITS. DISCRETIONARY SPENDING ACCOUNT INCLUDES SOCIAL CLUB DUES FOR CEO ONLY. ALL AMOUNTS INCLUDED IN TAXABLE COMPENSATION. PART I, LINE 1B TAX INDEMNIFICATION AND GROSS-UP PAYMENTS ARE PROVIDED WITH A WRITTEN POLICY. SOCIAL CLUB DUES ARE PROVIDED VIA EMPLOYMENT CONTRACT WITH CEO. PART I, LINE 7 NON-FIXED PAYMENTS, IN THE FORM OF BONUSES, ARE APPROVED BY THE BOARD COMPENSATION COMMITTEE. THE BONUSES ARE BASED ON PERFORMANCE INCLUDING LEADERSHIP. REVENUE IS NOT A BASIS FOR A BONUS. A PHILADELPHIA AUTHORITY FOR INDUSTRIAL DEVELOPMENT 232337287 2017-12-28 52857000 CAPITAL PROJECT FINANCING 0 0 0 B PHILADELPHIA AUTHORITY FOR INDUSTRIAL DEVELOPMENT 232337287 2017-12-28 4500000 CAPITAL PROJECT FINANCING LINE OF CREDIT 0 0 0 A 52857000 257000 52600000 2014 1 0 1 1 B 4500000 20000 4480000 2026 0 0 0 1 A 0 0 1 1 0 0.00000 0.00000 0.00000 0 0 1 B 0 0 1 1 0 0.00000 0.00000 0.00000 0 0 1 A 0 0 1 0 1 1 PNC BANK 10.000000000000 1 0 0 0 1 B 0 0 1 0 1 0 0 0 1 A 1 B 1 X 9 1772000 NYSE 0 0 1 0 PART I, COLUMN (B): THE NUMBER REPORTED IN COLUMN (B) LINE 9 IS THE NUMBER OF CONTRIBUTIONS. FORM 990, HEADER, LINE A THE INSTITUTE FILED TIMELY FORM 8868, APPLICATION FOR EXTENSION OF TIME TO FILE AND EXEMPT ORGANIZATION RETURN. FORM 990, PART VI, SECTION A, LINE 2 DANIEL WHEELER (TRUSTEE) AND ROBERT FOX (TRUSTEE) HAVE A FAMILY RELATIONSHIP. ROBERT FOX (TRUSTEE) (DECEASED APRIL 2021) AND RICHARD HOROWITZ (TRUSTEE) HAD A BUSINESS RELATIONSHIP. MORTON COLLINS (TRUSTEE) (DECEASED DECEMBER 2021) AND DAVID WEINER (KEY EMPLOYEE) HAD A BUSINESS RELATIONSHIP. FORM 990, PART VI, SECTION A, LINE 7A THE ACADEMY OF NATURAL SCIENCES AT DREXEL UNIVERSITY AND THE WISTAR FAMILY HAVE THE RIGHT TO DESIGNATE REPRESENTATION TO THE BOARD OF TRUSTEES. THE UNIVERSITY OF PENNSYLVANIA APPROVES APPOINTMENTS TO THE BOARD OF TRUSTEES UNDER THE INSTITUTE'S FOUNDING DEEDS OF TRUST. FORM 990, PART VI, SECTION A, LINE 7B THE ACADEMY OF NATURAL SCIENCES AT DREXEL UNIVERSITY AND THE WISTAR FAMILY HAVE THE RIGHT TO DESIGNATE REPRESENTATION TO THE BOARD OF TRUSTEES. THE UNIVERSITY OF PENNSYLVANIA APPROVES APPOINTMENTS TO THE BOARD OF TRUSTEES UNDER THE INSTITUTE'S FOUNDING DEEDS OF TRUST. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY THE CONTROLLER, EXTERNAL TAX ACCOUNTANT, AND CFO. AFTER ALL ADJUSTMENTS ARE MADE, THE DRAFT IS REVIEWED WITH THE PRESIDENT. THE FINAL DRAFT OF THE FORM 990 IS THEN REVIEWED WITH THE AUDIT COMMITTEE. THE INSTITUTE THEN POSTS A COPY TO THE BOARD'S WEBSITE AND NOTIFIES MEMBERS OF ITS AVAILABILITY FOR THEIR INFORMATION PRIOR TO SUBMISSION. FORM 990, PART VI, SECTION B, LINE 12C COVERED PERSONS ARE REQUESTED TO SUBMIT ANNUAL DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST FORMS WHICH ARE REVIEWED BY MANAGEMENT. COVERED PERSONS INCLUDE THE WISTAR INSTITUTE'S TRUSTEES, OFFICERS, "KEY EMPLOYEES", AND THE NEXT 5 HIGHLY COMPENSATED EMPLOYEES. AS DESCRIBED IN THE DISCLOSURE OF CONFLICT OF INTEREST POLICY, IF AN INDIVIDUAL HAS ANY POWER OR INFLUENCE TO APPROVE OR DISAPPROVE A CONTRACT OR TRANSACTION PROPOSED TO BE ENTERED INTO BETWEEN THE INSTITUTE AND ANY ENTITY OR PERSON HAVE A SIGNIFICANT RELATIONSHIP TO THAT INDIVIDUAL, THAT INDIVIDUAL HAS A POTENTIAL CONFLICT OF INTEREST AND MAY NOT PARTICIPATE IN THE PROCESS LEADING TO THE APPROVAL OR DISAPPROVAL OF THE CONTRACT OR TRANSACTION UNLESS UNDERLYING FACTS GIVING RISE TO THE POTENTIAL CONFLICT OF INTEREST ARE DISCLOSED AND APPROVAL FOR PARTICIPATION IS OBTAINED. IN THE CASE OF THE BOARD OF TRUSTEES, NO INDIVIDUAL WITH A POTENTIAL CONFLICT OF INTEREST WITH RESPECT TO A CONTRACT OR TRANSACTION OR ANY OTHER CONFLICT OF INTEREST MAY VOTE TO APPROVE OR DISAPPROVE THE CONTRACT OR TRANSACTION. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD OF TRUSTEES HAS DELEGATED AUTHORITY TO OVERSEE THE COMPENSATION PAID TO THE ORGANIZATION'S EXECUTIVES TO THE EXECUTIVE EVALUATION AND COMPENSATION COMMITTEE MADE UP EXCLUSIVELY OF INDEPENDENT MEMBERS OF THE BOARD OF TRUSTEES. THE COMMITTEE FOLLOWS THE PROCEDURES SET FORTH IN THE IRS REGULATIONS UNDER SECTION 4958 IN MAKING COMPENSATION DECISIONS. IN PARTICULAR, THE COMMITTEE ANNUALLY CONDUCTS A REVIEW OF EXECUTIVE COMPENSATION BASED ON INDEPENDENT COMPENSATION SURVEY INFORMATION. AT LEAST EVERY OTHER YEAR, THE COMMITTEE ENGAGES AN INDEPENDENT CONSULTANT TO COLLECT COMPARATIVE COMPENSATION DATA AND PROVIDE A WRITTEN OPINION ON THE REASONABLENESS OF THE PROPOSED COMPENSATION FOR EXECUTIVES. IN 2019, THE COMMITTEE BASED ITS REVIEW AND APPROVAL OF PROPOSED COMPENSATION ON INDEPENDENT DATA AND A REASONABLENESS OPINION PROVIDED BY AN INDEPENDENT COMPENSATION EXPERT DURING THE YEAR, AS WELL AS EMPLOYEE PERFORMANCE ASSESSMENTS AND MARKET TREND INFORMATION. THE COMMITTEE DOCUMENTED ITS COMPENSATION DECISION IN CONTEMPORANEOUS WRITTEN MINUTES. FORM 990, PART VI, SECTION C, LINE 19 THE INSTITUTE'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE ON THE INSTITUTE'S WEBSITE (WWW.WISTAR.ORG). THE INSTITUTE'S FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9: GAIN ON SPLIT-INTEREST AGREEMENTS 1,903,000. CHANGE IN CASH SURRENDER VALUE OF LIFE INSURANCE POLICIES 9,000. PENSION - NET GAIN 1,775,000. INTEREST RATE SWAP - NET GAIN 2,210,000. ISAAC J WISTAR FOUNDATION 3601 SPRUCE STREET PHILADELPHIA PA 19104 232593436 INACTIVE PA 501(C)(3) PF N/A 0 TALL CELL TECHNOLOGY LP C/O THE CONNELLY FDN ONE TOWER BRID WEST CONSHOHOCKEN PA 19428 232811246 LICENSING PA THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY EXCLUDED 148000 18000 0 1 0.90000 BENEFICIAL INTEREST IN CHARITABLE REMAINDER TRUST PNC WEALTH MANAGEMENT 620 LIBERTY AVE PITTSBURGH PA 15222 TRUST PA PNC BANK T 22000 238000 1.00000 0 BENEFICIAL INTEREST IN PERPETUAL TRUSTS BNY MELLON WEALTH MANAGEMENT 1735 MARKET STREET PHILADELPHIA PA 19103 TRUSTS PA BNY MELLON BANK T 1711000 19424000 1.00000 0 BENEFICIAL INTEREST IN PERPETUAL TRUSTS PNC INSTITUTIONAL INVESTMENTS 620 LIBERTY AVE PITTSBURGH PA 15222 TRUSTS PA PNC BANK T 168000 2236000 1.00000 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 TALL CELL TECHNOLOGY LP A 148000 COST